Facilitating Access to Cross-Border Supplies of Patented Pharmaceuticals: The Case of the COVID-19 Pandemic
Under the Radar: Reflections on ‘Forced’ Technology Transfer and the Erosion of Developmental Sovereignty
Legislative and Regulatory Takings of Intellectual Property: Early Stage Intervention Against a New Jurisprudential Virus
Public-Private Partnerships as Models for New Drug Development
Health and intellectual property rights
The UK Competition Appeal Tribunal’s Misguided Reprieve for Pfizer’s Excessive Pricing Abuse
Excessive Pricing and Sham Patent Litigation: The Pfizer and AbbVie Decisions
US Section 301, China, and technology transfer: Law and its limitations revisited (again)
